skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 6
Patent #:
NONE
Issue Dt:
Application #:
15477724
Filing Dt:
04/03/2017
Publication #:
20170202832
Pub Dt:
07/20/2017
Inventors:
Lorin K. Johnson, Jonathan Moss
Title:
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
Assignment: 1
Reel/Frame:
042689/0894Recorded: 06/13/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
JOHNSON, LORIN K.
Exec Dt:
10/06/2015
Assignee:
SALIX PHARMACEUTICALS, INC.
8510 COLONNADE CENTER DR.
RALEIGH, NORTH CAROLINA 27615
Correspondent:
MCCARTER & ENGLISH, LLP
245 PARK AVENUE
27TH FLOOR
NEW YORK, NY 10167-0001
Assignment: 2
Reel/Frame:
042689/0902Recorded: 06/13/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
MOSS, JONATHAN
Exec Dt:
11/04/2015
Assignee:
UNIVERSITY OF CHICAGO
5801 S. ELLIS AVENUE
CHICAGO, ILLINOIS 60637
Correspondent:
MCCARTER & ENGLISH, LLP
245 PARK AVENUE
27TH FLOOR
NEW YORK, NY 10167-0001
Assignment: 3
Reel/Frame:
043379/0809Recorded: 07/31/2017Pages: 5
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 042689 FRAME 0902. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignor:
MOSS, JONATHAN
Exec Dt:
11/04/2015
Assignee:
THE UNIVERSITY OF CHICAGO
5801 S. ELLIS AVENUE
CHICAGO, ILLINOIS 60637
Correspondent:
MCCARTER & ENGLISH, LLP
245 PARK AVENUE
27TH FLOOR
NEW YORK, NY 10167-0001
Assignment: 4
Reel/Frame:
045444/0299Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE
NEW YORK, NEW YORK 10019
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 5
Reel/Frame:
045444/0634Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
101 BARCLAY STREET
FLOOR 7E
NEW YORK, NEW YORK 10286
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 6
Reel/Frame:
048556/0758Recorded: 03/11/2019Pages: 39
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BAUSCH HEALTH AMERICAS, INC.
Exec Dt:
03/08/2019
BAUSCH & LOMB INCORPORATED
Exec Dt:
03/08/2019
BAUSCH HEALTH US, LLC
Exec Dt:
03/08/2019
SOLTA MEDICAL, INC.
Exec Dt:
03/08/2019
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
03/08/2019
SALIX PHARMACEUTICALS, INC.
Exec Dt:
03/08/2019
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
03/08/2019
SANTARUS, INC.
Exec Dt:
03/08/2019
ORAPHARMA, INC.
Exec Dt:
03/08/2019
PRECISION DERMATOLOGY, INC.
Exec Dt:
03/08/2019
Assignee:
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET
ATTN: CORPORATE TRUST ADMINISTRATION
NEW YORK, NEW YORK 10286
Correspondent:
JAY DASILVA
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005

Search Results as of: 05/10/2024 09:43 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT